Vioxx (Rofecoxib) was on the shelves from 1999 to 2004, prescribed to patients as a pain-reliever for arthritis, osteoarthritis, menstrual pain, and other acute pain. Vioxx was recalled and pulled off the market when it was linked to deadly side effects heart attack, stroke, kidney damage, and arrythmia.
If you consulted a Vioxx lawyer who declined your Vioxx case because you did not suffer a heart attack, or you did not receive a response from an Vioxx attorney, please re-submit your complaint. Or if you have taken Vioxx for as little as two weeks and suffered a heart attack, please re-submit your complaint.
Vioxx is a Cox-2 inhibitor that was approved by the US Food and Drug Administration in 1999 for the treatment of arthritis, osteoarthritis, menstrual pain and for the management of acute pain in adults. Serious concerns have been raised in recent months regarding the use of Vioxx and Vioxx side effects on kidney and cardiovascular health, and the increased risk of heart attack and stroke.
Vioxx is an anti-inflammatory drug, which means it reduces internal inflammation. Vioxx, along with Aspirin, is part of the class of drugs known as nonsteroidal anti-inflammatory drugs (NSAID) - i.e. it is not a steroid. Vioxx is an analgesic and antipyretic drug, reducing pain and fever. Vioxx's active ingredient is rofecoxib.
Vioxx Recall & FDA AdvisoryVioxx was pulled off the shelves worldwide in September 2004 after a clinical study confirmed concerns that it raises the risk of heart attack and stroke, which can lead to serious and permanent injuries and death. More than 2 million people worldwide have used Vioxx.
Complications may begin approximately 18 months after patients start taking Vioxx. Previous clinical trials have linked Vioxx to an increase in blood clots and other cardiovascular problems, including heart attack, chest pain related to heart disease, stroke and sudden death. According to one clinical study, Vioxx users were more than twice as likely to experience heart problems than patients using the control drug.
All NSAIDs have some risks of side effects pain and gastrointestinal bleeding, and liver and kidney toxicity. Bextra, another NSAID has also been recalled.
FDA Public Health Advisory about VioxxThe FDA public health advisory on Vioxx safety. [US FDA]
Vioxx ArticlesMerck & Co. to Pay $4.85 Billion in Personal Injury Cases Due to Vioxx
Vioxx is the impetus feeding the fire of over 44,000 personal injury lawsuits being exacted against Pharmaceutical manufacturer Merck & Co. The drug has caused several incidences of heart ailments, strokes, and even cases of death from its side effects. The former painkiller was eliminated from the market in 2004. The 44,000 personal injury cases are just from plaintiffs in the United States. Former patients that used Vioxx in 18 other nations have stepped forward demanding a refund for the money spent on the drug. Also, health care professionals and stockholders in these nations are demanding repayment for the losses they've incurred from the drug going South. Fresh lawsuits from overseas areas continue to come in.
Vioxx Settlement: Merck Offers $4.85 Billion
In a stunning announcement that also provides a peek into the vaults of a pharmaceutical giant, it was revealed late yesterday that Merck & Co. Inc has thrown the first volley that it hopes will result in a settlement of Vioxx lawsuits to the tune of $4.85 billion.
FDA Colludes With Merck To Avoid Vioxx Liability - Part II
Legal experts say the recent court ruling in Bush's home state of Texas that failure-to-warn claims against Merck by Vioxx victims in state courts are preempted is particularly egregious due to the FDA's failure to protect the public against Merck's deceptive mass-marketing of Vioxx as a safe drug for basically 5 years.
FDA Colludes With Merck To Avoid Vioxx Liability - Part I
Vioxx: The Heart Attack Window Keeps Shrinking
Vioxx Stroke Risk could last for Years
Merck Has No Plan To Pay Vioxx Victims
Merck Vioxx Litigation Score Card
Merck Insurance Carriers jump ship over Vioxx Disaster
Merck still fighting Vioxx lawsuits Individually
Merck not losing Sleep over Vioxx Disaster
Merck Legal Team Makes a Killing off Losing Vioxx Strategy
Vioxx should have Warned Us of Side Effects
Merck Litigation Strategy - Destroy Expert Witnesses
Merck Caught misrepresenting Vioxx Risks Again
FDA Used to Shield Big Pharma from Lawsuits
FDA Shields Drug Companies from Lawsuits
Vioxx Lawsuits In the NewsMAY-31-07: Merck faces nearly 27,300 lawsuits from people who claim they were harmed by Vioxx, which was pulled from the market after a study showed that patients who took the drug for at least eight months had twice the risk of heart attack and stroke. [WISTV: VIOXX]
MAY-30-07: A judge has ordered a third trial in a lawsuit filed by a woman who blamed Vioxx for the death of her husband. In the second trial, jurors ruled in favor of Merck on the basis of testimony from a cardiologist who misrepresented his qualifications. [FORBES: VIOXX]
MAY-24-07: Vioxx was designed to reduce pain and inflammation without causing the bleeding associated with aspirin. However, it was pulled from the market after a study linked it to an increased risk of heart attack and stroke. [ PLAIN DEALER: VIOXX]
MAY-17-07: A bill passed in Oregon will help lawsuits against Vioxx proceed. The bill fixes a glitch that limited some people from suing Merck for injury caused by taking Vioxx. [JOURNAL: VIOXX]
MAY-08-07: A recent study has found that the risk of dying from Vioxx is about the same as the risk of dying in a car, working as a truck driver, or rock climbing. Furthermore, the risks from Vioxx are equal to or higher than the risk of death for firefighters and law enforcement workers. [FORBES: VIOXX]
MAY-02-07: A West Virginia lawsuit that claims Vioxx was responsible for a man's death has been scheduled for October. [INSURANCE JOURNAL: VIOXX]
APR-29-07: A landmark trial that claims Vioxx is the cause of a man's death is scheduled to begin in October. The plaintiff's lawyer argues that Vioxx caused five times more heart attacks as other pain-relief medications. [GAZETTE: VIOXX]
APR-27-07: Merck has failed in its bid to get FDA approval for Vioxx's successor, Arcoxia. Vioxx has become widely-known for its safety problems and Merck failed to provide proper safety data for Arcoxia. [FORBES: VIOXX]
APR-26-07: An attorney has filed a lawsuit against the FDA claiming that materials he requested regarding Vioxx three years ago under the Freedom of Information Act still have not been sent to him. [STAR-LEDGER: VIOXX]